Company Filing History:
7 out of 932 
1 out of 446 
1 out of 832,680 Years Active: 2000-2010
Title: Innovations and Contributions of Inventor Michel Roberge
Introduction
Michel Roberge is a notable inventor based in Vancouver, Canada, recognized for his significant contributions to the field of pharmaceuticals. With a total of eight patents to his name, Roberge has focused on developing innovative solutions for various medical conditions.
Latest Patents
Among his latest patents, Roberge has developed indoleamine 2,3-dioxygenase (IDO) inhibitors. These inhibitors are crucial for treating conditions characterized by pathology in the IDO-mediated tryptophan metabolic pathway. Such conditions may include suppression of T-cell mediated immune response, depletion of tryptophan, and accumulation of tryptophan degradation products. Specific diseases targeted by these inhibitors include cataracts, neurodegenerative disorders, mood disorders, cancer, and various bacterial and viral infections. The IDO inhibitors developed by Roberge feature substituted naphthalene and anthracene diones, with novel compounds including taurine-substituted naphthaquinone structures. Additionally, he has worked on biologically active peptides and compositions derived from hemiasterlin or Geodiamolide G, which exhibit anti-mitotic activities useful in cancer treatment.
Career Highlights
Roberge's career has been marked by his association with prestigious institutions such as the University of British Columbia and the University of Alberta. His work in these academic environments has
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.